|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: POLYMER SOLUTIONS INC, 10-K, EX-21.1, 2000-06-22 |
Next: NEXELL THERAPEUTICS INC, 8-K, 2000-06-22 |
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from form 10-k
and is qualified in its entirety by reference to such financial statements.
</LEGEND>
<S> <C>
<PERIOD-TYPE> YEAR
<FISCAL-YEAR-END> MAR-31-2000
<PERIOD-START> APR-01-1999
<PERIOD-END> MAR-31-2000
<CASH> 65,097
<SECURITIES> 0
<RECEIVABLES> 2,374,065
<ALLOWANCES> 20,000
<INVENTORY> 1,523,947
<CURRENT-ASSETS> 4,583,469
<PP&E> 1,686,011
<DEPRECIATION> 860,359
<TOTAL-ASSETS> 6,649,093
<CURRENT-LIABILITIES> 1,872,377
<BONDS> 0
0
0
<COMMON> 8,855
<OTHER-SE> 11,501,420
<TOTAL-LIABILITY-AND-EQUITY> 6,649,093
<SALES> 13,121,376
<TOTAL-REVENUES> 13,121,376
<CGS> 9,028,728
<TOTAL-COSTS> 3,204,516
<OTHER-EXPENSES> 34,900
<LOSS-PROVISION> 20,000
<INTEREST-EXPENSE> 287,695
<INCOME-PRETAX> 635,337
<INCOME-TAX> (470,000)
<INCOME-CONTINUING> 0
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 1,105,337
<EPS-BASIC> 0.14
<EPS-DILUTED> 0.14
</TABLE>
|
|